CB-5083
p97/VCP ATPase inhibitor (PDE6 off-target) Ph. I in cancer (discont., dyschromatopsia) from HTS of NIH compound library J. Pharmacol. Exp. Ther., Apr. 30, 2021 Cleave Therapeutics, San Francisco, CA
Molecules of the Month - April 2021
Molecules of the Month
- RM-018
- GDC-0334
- BAY 1101042 (runcaciguat)
- AG-270
- NJH-2-057
- basmisanil
- STM-2457
- compound 28
- VT-104
- CB-5083
- compound 20p
- SHR168442
- GNE-9815
- ABD957